Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Balsalazide Disodium Dihydrate in UC Research
2026-08-23
Balsalazide disodium is a colon-directed 5-aminosalicylic acid prodrug that is activated by bacterial azoreductase. Research data support its use in inflammation research, radiolabeling workflows, and inflammatory bowel disease models, but animal imaging results do not establish clinical diagnostic use.
-
AP20187: Programmable Control for Translational Biology
2026-08-22
AP20187 is a chemical inducer of dimerization that converts engineered receptor signaling into a controllable research variable. This thought-leadership article connects its mechanism to conditional gene expression, regulated cell therapy, metabolic research, and immune-driven pain biology while defining practical validation and translational boundaries.
-
Baicalin Workflows for Adult Visual Plasticity
2026-08-22
A dose-aware Baicalin workflow translates evidence from adult amblyopic mice into practical imaging, electrophysiology, and mechanism-control experiments. The same compound can support carefully separated exploratory studies in oxidative stress and cancer research, provided visual-cortex findings are not overextended to oncology.
-
Niclosamide B2283 for Reliable Cell Assays
2026-08-21
Learn how Niclosamide (SKU B2283) can support reproducible viability, proliferation, cell-cycle, and apoptosis workflows through documented STAT3 activity, solvent compatibility, and handling guidance. This scenario-based guide helps researchers distinguish compound effects from formulation and assay-design artifacts.
-
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody Guide
2026-08-20
The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody enables fluorescence detection of goat-derived IgG primary antibodies in ICC/IF, IHC, flow cytometry, and ELISA workflows. It should not be used as a universal secondary antibody for non-goat primaries or outside validated immunodetection protocols.
-
BX795: PDK1 Inhibitor for TBK1 and IRF3 Assays
2026-08-20
BX795 combines nanomolar PDK1 inhibition with activity against TBK1 and IKKε, enabling connected studies of AKT2 signaling, IRF3 regulation, autophagy, and cancer phenotypes. This guide converts that dual-pathway profile into practical kinase, immune-signaling, and cell-based workflows with built-in controls and troubleshooting.
-
Cy3 NHS ester (non-sulfonated): Practical Guide
2026-08-19
Cy3 NHS ester (non-sulfonated) provides a reactive fluorescent handle for labeling primary amino groups on proteins, peptides, oligonucleotides, and DNA. Because it is water-insoluble and requires an organic co-solvent, it is best used in workflows that tolerate controlled DMSO or DMF exposure, rather than with delicate biomolecules requiring strictly aqueous conditions.
-
Phosbind Acrylamide: Practical Phosphorylation Workflows
2026-08-19
Phosbind Acrylamide enables antibody-free separation of phosphorylated and non-phosphorylated proteins during SDS-PAGE phosphorylation detection. This guide translates a recent apple cold-signaling discovery into practical gel design, workflow controls, and troubleshooting decisions for protein phosphorylation analysis.
-
MMP-2-Responsive Peptide Therapy for Breast Cancer
2026-08-18
The reference study developed a self-assembling peptide nanoparticle that responds to tumor-associated matrix metalloproteinase 2 (MMP-2), changes morphology, and co-delivers doxorubicin with indomethacin. This design improved intracellular drug retention, promoted immunogenic cell death, influenced CD4+ T-cell activity, and suppressed breast cancer growth in the reported experimental models.
-
Cy3 Goat Anti-Human IgG (H+L) Antibody Guide
2026-08-18
Build sensitive human IgG detection workflows across immunofluorescence assay, immunohistochemistry, flow cytometry, and ELISA. This practical guide connects Cy3 signal optimization with antibody-characterization strategies while highlighting species controls, storage discipline, and troubleshooting limits.
-
Nile Red: From Lipid Droplets to Translational Evidence
2026-08-17
Nile Red, also known as Nile blue oxazone, can turn lipid-droplet phenotypes into structured translational evidence. This thought-leadership guide connects dual-channel fluorescence, rigorous validation, and assay strategy for lipid metabolism research while defining the boundaries between imaging signal, mechanism, and clinical relevance.
-
hiPSC Intestinal Organoids for Pharmacokinetic Studies
2026-08-17
Saito and colleagues developed a direct three-dimensional culture workflow for generating expandable intestinal organoids from human induced pluripotent stem cells. The organoids can be propagated, cryopreserved, and differentiated into intestinal epithelial cells with functional enterocyte drug-metabolizing enzymes and transporters, creating a practical human model for oral drug pharmacokinetics.
-
Superoxide Dismutase Activity Assay Kit Guide
2026-08-16
Learn how to use the Superoxide Dismutase Activity Assay Kit for rapid, functional measurement of antioxidant capacity in biological samples. This workflow also shows when a WST-1 colorimetric SOD Activity Assay is preferable to fluorescent hydrogen peroxide measurements and how to control matrix-related errors.
-
Rotigotine: Receptor Signaling to Bladder Function
2026-08-15
Rotigotine is a dopamine D2/D3 receptor agonist with applications spanning neuroprotection, motor control, and Parkinson’s disease-related bladder dysfunction. This article translates route-dependent preclinical findings into a practical framework for designing receptor, cellular, and cystometry assays.
-
Primary Antibody Dilution Buffer for PCNSL Assays
2026-08-14
Learn how Primary Antibody Dilution Buffer K1200 can support spatial validation of SLC2A5-linked metabolic states in primary CNS lymphoma. This article connects single-cell discovery with reproducible IHC, ICC, and antibody-based ISH assay design.